KOVÁČ, Daniel, Jiří MEKYSKA, Vered AHARONSON, Pavol HARAR, Zoltan GALAZ, Steven RAPCSAK, Juan Rafael OROZCO-ARROYAVE, Luboš BRABENEC and Irena REKTOROVÁ. Exploring digital speech biomarkers of hypokinetic dysarthria in a multilingual cohort. Biomedical Signal Processing and Control. OXFORD: ELSEVIER SCI LTD, 2024, vol. 88, B, p. 1-11. ISSN 1746-8094. Available from: https://dx.doi.org/10.1016/j.bspc.2023.105667.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Exploring digital speech biomarkers of hypokinetic dysarthria in a multilingual cohort
Authors KOVÁČ, Daniel (203 Czech Republic), Jiří MEKYSKA (203 Czech Republic), Vered AHARONSON, Pavol HARAR, Zoltan GALAZ, Steven RAPCSAK, Juan Rafael OROZCO-ARROYAVE, Luboš BRABENEC (203 Czech Republic, belonging to the institution) and Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Biomedical Signal Processing and Control, OXFORD, ELSEVIER SCI LTD, 2024, 1746-8094.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30401 Health-related biotechnology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.100 in 2022
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1016/j.bspc.2023.105667
UT WoS 001108281100001
Keywords in English Hypokinetic dysarthria; Parkinson's disease; Multilingual study; Acoustic speech features; Statistical analysis; Machine learning
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 3/3/2024 22:42.
Abstract
Hypokinetic dysarthria, a motor speech disorder characterized by reduced movement and control in the speech -related muscles, is mostly associated with Parkinson's disease. Acoustic speech features thus offer the potential for early digital biomarkers to diagnose and monitor the progression of this disease. However, the influence of language on the successful classification of healthy and dysarthric speech remains crucial. This paper explores the analysis of acoustic speech features, both established and newly proposed, in a multilingual context to support the diagnosis of PD. The study aims to identify language-independent and highly discriminative digital speech biomarkers using statistical analysis and machine learning techniques. The study analyzes thirty-three acoustic features extracted from Czech, American, Israeli, Columbian, and Italian PD patients, as well as healthy controls. The analysis employs correlation and statistical tests, descriptive statistics, and the XGBoost classifier. Feature importances and Shapley values are used to provide explanations for the classification results. The study reveals that the most discriminative features, with reduced language dependence, are those measuring the prominence of the second formant, monopitch, and the frequency of pauses during text reading. Classification accuracies range from 67% to 85%, depending on the language. This paper introduces the concept of language robustness as a desirable quality in digital speech biomarkers, ensuring consistent behaviour across languages. By leveraging this concept and employing additional metrics, the study proposes several language-independent digital speech biomarkers with high discrimination power for diagnosing PD.
Links
LX22NPO5107, research and development projectName: Národní ústav pro neurologický výzkum
Investor: Ministry of Education, Youth and Sports of the CR, 5.1 EXCELES
NU20-04-00294, research and development projectName: Diagnostika onemocnění s Lewyho tělísky v prodromálním stadiu založená na analýze multimodálních dat
Investor: Ministry of Health of the CR, Diagnostics of Lewy body diseases in prodromal stage based on multimodal data analysis
734718, interní kód MUName: Novel Network-Based Approaches for Studying Cognitive Dysfunction in Behavioral Neurology (Acronym: CoBeN)
Investor: European Union, MSCA Marie Skłodowska-Curie Actions (Excellent Science)
PrintDisplayed: 17/7/2024 09:30